SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882104-20-000217
Filing Date
2020-12-31
Accepted
2020-12-31 18:48:57
Documents
1
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160945852572791.html 4  
1 FORM 4 wf-form4_160945852572791.xml 4 3047
  Complete submission text file 0000882104-20-000217.txt   4482
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 749 N MARY AVE SUNNYVALE CA 94085
Business Address
GRYSKA DAVID W (Reporting) CIK: 0001202335 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 201429704